Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Theravance, Inc.”

369 pharma patents match "Theravance, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 369
Index total 30,257
Page 7 / 16

Quick answer

This filtered view shows 369 pharmaceutical patents matching "Theravance, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

369 results for “Theravance, Inc.” · 30,257 patents in full index Clear search

  1. US 7956054

    Dual-acting pyrazole antihypertensive agents

    Theravance, Inc. · Granted Jun 7, 2011 · Expires Jun 2, 2031

    granted

  2. US 7947710

    Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted May 24, 2011 · Expires May 19, 2031

    granted

  3. US 7943772

    Crystalline forms of an 8-azabicyclo(3.2.1)octane compound

    Theravance, Inc. · Granted May 17, 2011 · Expires May 12, 2031

    granted

  4. US 7939689

    Short-acting sedative hypnotic agents for anesthesia and sedation

    Theravance, Inc. · Granted May 10, 2011 · Expires May 5, 2031

    granted

  5. US 7910608

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Mar 22, 2011 · Expires Mar 17, 2031

    granted

  6. US 7902148

    Use of an echinocandin antifungal agent in combination with a glycopeptide antibacterial agent

    Theravance, Inc. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  7. US 7902221

    Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  8. US 7902220

    8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted

  9. US 7897775

    Crystalline form of a benzimidazole-carboxamide medicinal compound

    Theravance, Inc. · Granted Mar 1, 2011 · Expires Feb 24, 2031

    granted

  10. US 7893256

    Azabicycloalkane compounds

    Theravance, Inc. · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  11. US 7888386

    3-(phenoxyphenylmethyl)pyrrolidine compounds

    Theravance, Inc. · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted

  12. US 7880010

    Crystalline forms of a dimethylphenyl compound

    Theravance, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  13. US 7879896

    Dual-acting imidazole antihypertensive agents

    Theravance, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  14. US 7879879

    Biphenyl derivatives

    Theravance, Inc. · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted

  15. US 7875629

    Quinolinone compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted

  16. US 7871997

    Cephalosporin compounds

    Theravance, Inc. · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted

  17. US 7868175

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted

  18. US 7863309

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted

  19. US 7858583

    Process for purifying glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  20. US 7858792

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  21. US 7858795

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  22. US 7858797

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 28, 2010 · Expires Dec 23, 2030

    granted

  23. US 7855221

    Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid

    Theravance, Inc. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted

  24. US 7851632

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.